Brendan Frey ^UDM

Brendan Frey, Founder and CEO of Deep Genomics and a professor at the University of Toronto, is at the forefront of using AI for genetic therapy development. His leadership and expertise are central to Deep Genomics' mission to create life-saving genetic treatments. Frey's work exemplifies the future of medicine, where AI plays a crucial role in understanding the complexity of biology and developing innovative therapies.